NCT06198738

Brief Summary

Prospective, multicentric, observational study aimed to evaluate the correlation between the value of the InTraocular EMulsion of Silicone oil (ITMES) score assessed at clinical examination and silicone oil-related ocular complications. This will allow to clinically validate the ITEMS score, as clinical tool. Demographic data and clinical findings, including the ITEMS score, of patients undergoing to vitrectomy and silicone oil tamponade or removal of silicone oil or having one silicone oil-filled eye, will be collected at the baseline and at each follow-up visit (at 1-day, 1-, 3- and 6-month after surgery). The prognostic performance of the ITEMS score will be evaluated in agreement with the TRIPOD statement.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
323

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2024

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 27, 2023

Completed
5 days until next milestone

Study Start

First participant enrolled

January 1, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 10, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

January 18, 2024

Status Verified

January 1, 2024

Enrollment Period

11 months

First QC Date

December 27, 2023

Last Update Submit

January 17, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Correlation between the value of the ITMES score and any silicone oil-related ocular complication

    The InTraocular EMulsion of Silicone oil (ITEMS) grading system has been proposed for the assessment of silicone oil emulsion to more reliably quantify the presence and extent of any SO emulsion, applicable in a daily clinical setting and validated through an expert panel consensus procedure (Romano MR, et al, INTRAOCULAR EMULSION OF SILICONE OIL (ITEMS) GRADING SYSTEM: An Evidence-Based Expert-Led Consensus. Retina 2023 Aug 1;43(8):1370-1376)

    Baseline, 1 day, 1 month, 3 months and 6 months

Secondary Outcomes (4)

  • Correlation between the value of the ITMES score and any single types of intraoperative silicone oil-related ocular complication

    Baseline, 1 day, 1 month, 3 months and 6 months

  • Correlation between the value of the ITMES score and any single types of postoperative silicone oil-related ocular complication

    Baseline, 1 day, 1 month, 3 months and 6 months

  • Correlation between the value of the ITMES score and postoperative retinal attachment

    Baseline, 1 day, 1 month, 3 months and 6 months

  • Correlation between the value of the ITMES score and postoperative best-corrected visual acuity

    Baseline, 1 day, 1 month, 3 months and 6 months

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All adult patients meeting the inclusion criteria

You may not qualify if:

  • untreated or uncontrolled ocular disease leading to unacceptable higher risk of intra- and post-operative complications, such as uncontrolled ocular inflammation or infection, untreated ocular malignancy and uncontrolled glaucoma;
  • uncontrolled severe systemic disease related to significantly higher operative risk;
  • pregnant women due to the specific risks related to supine position during surgery, operative time, risks of retrobulbar anesthesia, and intraoperative and postoperative drugs;
  • inability to give written consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Mario R Romano, MD PhD

CONTACT

Mariantonia Ferrara, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 27, 2023

First Posted

January 10, 2024

Study Start

January 1, 2024

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

January 18, 2024

Record last verified: 2024-01